Jasper E. Neggers, Ph.D.

Jasper E. Neggers, Ph.D. is a Co-Founder and Chief Scientific Officer at Promakhos Therapeutics since April 2021. Previously, Jasper held various research and teaching positions at institutions such as Dana-Farber Cancer Institute, Harvard Medical School, and Broad Institute of MIT and Harvard. Jasper's work has focused on identifying and validating therapeutic targets for cancer, particularly in chromosome 16q and/or 18q-deficient cancers. Jasper has a strong background in biomedical sciences, holding a PhD from KU Leuven and a postdoctoral research fellowship from Harvard Medical School. Additionally, Jasper has experience in web development as a Co-Founder of Miniprise VOF.